Democrats tore into an Environmental Protection Agency (EPA) plan Wednesday that would bar the agency from relying on scientific studies that don’t release their underlying data — a controversial proposal resurfacing this week with reports that the agency may expand the reach of the rule.
The proposal — which the agency said will not be finalized until next year — was pushed by former Administrator Scott Pruitt as an attempt to battle “secret science.” But it has proven to be one of the EPA’s most widely panned measures, garnering more than 600,000 comments, many of which argue the effort won’t promote transparency but will instead undercut the agency’s ability to rely on the best available science.
Many of the nation’s top medical, science and public health groups were among those who have opposed the rule.{mosads}
“These efforts pay cheap lip service to improving scientific integrity and transparency, but their true purpose is to undermine the decades of sound science on which EPA relies to protect our air, water and the health and safety of the American people,” Rep. Paul Tonko (D-N.Y.) said at House Science, Space and Technology Committee hearing, noting that Congress has repeatedly chosen not to forward similar proposals when they were introduced by lawmakers in years past.
“Any form of this rule essentially guarantees that political agendas are given more weight than science in EPA rule-making.”
EPA sent a longtime career employee, Jennifer Orme-Zavaleta, who heads the Office of Research and Development, to take questions from lawmakers.
She told Tonko that EPA is still considering the comments, and while many supported the concept of transparency, “where they differed were in the way in which we approached that.”
But while Orme-Zavaleta answered questions inside, the agency was busy defending the proposal on Twitter.
“Science transparency does not weaken science, quite the contrary. By requiring transparency, scientists will be required to publish hypothesis and experimental data for other scientists to review and discuss, requiring the science to withstand skepticism and peer review,” the agency wrote.
Numerous lawmakers, as well as witnesses from scientific and medical groups in a second panel, compared the rule to tactics used by the tobacco industry, which focused not on the public relations nightmare of questioning the health risks of smoking, but instead zeroed in on undercutting the scientific methods used to draw that conclusion.
Democratic lawmakers seized on whether career staff were consulted in the development of the rule and how it might impact regulations going forward.
Rep Bill Foster (D-Ill.) asked if the proposal was crafted in a fashion that was bottom-up, “where the scientific staff, the career people in the EPA have come up with the first drafts,” or top-down, “where the political appointees consult with whoever they consult with and come up with a draft and then you’re at best asked to comment?”
Orme-Zavaleta said she was not involved in drafting the rule, saying it was crafted “outside of me.”
But Foster, noting that everyone above Orme-Zavaleta was a political appointee, said he was concerned by that.
“Congress has considered and rejected a lot of these ‘secret science’ proposals for good reason so you can understand why we might not be comfortable with having the final call on these made by a coal lobbyist,” Foster said in reference to EPA Administrator Andrew Wheeler.
Republicans repeatedly grumbled that the committee was premature, held before the rule had been finalized, while bashing a New York Times story that reported on a draft supplement to the rule that the agency has said is old and has not been forwarded.
“I’m glad the EPA is working toward transparency, and sad it’s been maligned by the media,” said Rep. Bill Posey (R-Fla.).
Posey accused the agency in the past of forwarding a political agenda using “secret science” at the hands of “unelected, unaccountable, unrecallable bureaucrats.”
But Democrats said the proposal, both what has already been made public by the EPA as well as the draft reported on by the Times, would significantly restrict the agency’s ability to consider some landmark studies and could impact old regulations that rely on studies that kept participants’ information private in order to protect sensitive health data.
“Currently scientists don’t share that data for ethical and legal reasons,” said Rep. Lizzie Fletcher (D-Texas), adding that the EPA should reconsider a rule that could have “a chilling effect on research overall.”
Orme-Zavaleta stressed that the rule would not be applied retroactively and that the EPA administrator could always make an exception for any study deemed too important to exclude.
She also said the EPA’s Science Advisory Board was looking into how the agency should deal with sensitive personally identifiable information and confidential business information.
But many critics say the board was not given enough time to review the proposal overall or help craft a fix for sensitive information, hoping to fast-track those recommendations and turn them over by the end of the year — just before EPA is set to release its science transparency rule.
Rep. Suzanne Bonamici (D-Ore.) has asked the EPA to hold off on finalizing a rule until the National Academy of Sciences can conduct a review. She sent a letter to the group Wednesday asking for their analysis.
In a second panel filled with scientific and medical experts, each was asked whether they supported the EPA’s proposal.
Even the GOP-invited witness, Center for Open Science Executive Director Brian Nosek, said he did not.